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Tyrosine hydroxylase purified from rat pheochromocytoma is phosphorylated rapidly by the Ca2+- and 
phospholipid-dependent protein kinase (protein kinase C) purified from rat or sheep brain. Phosphorylation 
was stimulated 1Cfold by Ca*+ and phosphatidylserine and occurred at a rate comparable with that of the 
phosphorylation of histone HI. The phospholipid-dependent protein kinase phosphorylates a single site 
which is identical to that phosphorylated by cyclic AMP-dependent protein kinase and to the secondary 
site of phosphorylation by the calmodulin-dependent multiprotein kinase. The implications of these results 
with respect o the regulation of catecholamine biosynthesis in adrenal medulla are discussed. 
Tyrosine hydroxylase Phosphorylation Cyclic AMP-depdent protein kinase 
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1. INTRODUCTION 
Treatment of dissociated adrenal chromaffin 
cells with either acetylcholine or cyclic AMP 
analogues leads to stimulation of catecholamine 
biosynthesis and activation of the rate-limiting en- 
zyme in this pathway, tyrosine hydroxylase [l-3]. 
Since purified tyrosine hydroxylase is phosphory- 
lated and activated in vitro by cyclic AMP-de- 
pendent protein kinase [4-61, it has been suggested 
that cyclic AMP is involved in mediating the ef- 
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fects of acetylcholine [2,3]. However, while acetyl- 
choline has been reported to increase cyclic AMP 
levels in chromaffin cells [7], this is not always 
observed [l]. In addition, stimulation of catechol- 
amine biosynthesis by acetylcholine, and by the 
depolarizing agents K+ and veratridine, is depen- 
dent on the presence of Ca’+ in the external 
medium, and the pathway is also activated by the 
Ca2+ ionophore A23187. These observations sug- 
gest that the effects of acetylcholine on chromaffin 
cells may be mediated by Ca2+ rather than cyclic 
AMP. 
Recently, tyrosine hydroxylase purified from a 
catecholamine secreting adrenal tumour has been 
shown to be phosphorylated by the calmodulin- 
dependent multiprotein kinase from rabbit skeletal 
muscle [8]. Here, we report that another 
Ca’+-dependent protein kinase, the Ca2+ and 
phospholipid-dependent protein kinase (protein 
kinase C), also phosphorylates tyrosine hydrox- 
ylase. The sites that are phosphorylated by the two 
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Ca*+-dependent protein kinases and cyclic AMP- 
dependent protein kinase have been compared by 
HPLC peptide mapping and by Edman degrada- 
tion of phosphorylated peptides, as a preliminary 
approach to determine which, if any of these pro- 
tein kinases, mediates the effect of acetylcholine in 
vivo. 
2. MATERIALS AND METHODS 
2.1. Materials 
Phosphatidylserine, mixed histone (Type IIA) 
and lysine-rich histone (Type III-S) were from 
Sigma (Dorset, UK); trypsin (TPCK-treated) from 
Worthington/Millipore (NJ, USA); bovine serum 
albumin (fraction V) from BDH Chemicals 
(Dorset, UK), and ]y-32P]ATP from Amersham 
International (Bucks, UK). 
Tyrosine hydroxylase was purified from rat 
pheochromocytoma [S]; the catalytic subunit of 
cyclic AMP-dependent protein kinase [9] and the 
calmodulin-dependent multiprotein kinase [lo] 
from rabbit skeletal muscle. The Ca2+ and 
phospholipid-dependent protein kinase was 
purified from rat brain ([ll]; DEAE-trisacryl 
method), or sheep brain (as in 1121; final phenyl- 
Sepharose step omitted). Calmodulin was purified 
from sheep brain [13], and histone-Hl from com- 
mercial mixed histone (type IIA) as in [ 141. 
2.2. Methods 
Assay procedures and units of activity for cyclic 
AMP-dependent protein kinase [ 151, calmodulin- 
dependent protein kinase [lo] and phospholipid- 
dependent protein kinase [ 121 have been defined 
previously, except that in the present paper units 
are pmol phosphate incorporated per min rather 
than nmol per min. Tyrosine hydroxylase was 
phosphorylat~d in incubations (50 ~1) containing 
tyrosine hydroxylase (0.11 mg/ml), [T-~~P]ATP 
(0.2 mM; 4 x lo5 cpm/nmol) and magnesium 
acetate (5 mM) in 25 mM sodium-Hepes buffer 
(pH 7.0) containing 0.5 mM EDTA and 0.5 mM 
dithiothreitol. Further additions were: (1) catalytic 
subunit of cyclic AMP-dependent protein kinase 
plus EGTA (0.1 mM); (2) calmodulin-dependent 
protein kinase plus CaClz (1 mM) and calmodulin 
(10 @g/ml); or (3) phospholipid-dependent protein 
kinase plus CaCl2 (1 mM) and phosphatidylserine 
(5O~g/mI). Amounts of protein kinase added are 
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detailed in figure legends. Reactions were started 
by the addition of ATP, and incorporation of 
phosphate into protein was determined as in [16]. 
Tryptic peptides were prepared and separated by 
reversed-phase HPLC as in [8] except that an Altex 
Ultrasphere ODS column (25 x 0.4 cm) was used, 
and radioactivity in the column effluent was 
monitored continuously with a Reeve Analytical 
Monitor using the Cerenkov effect. For isoelectric 
focussing, fractions were dried down in vacua and 
analysed as in [ 1’71. Automated Edman degrada- 
tion was carried out on HPLC fractions using a 
Beckman 89OC sequencer as in [ 181. The 
butylchloride extract from each cycle was dried, 
mixed with 5 ml optiphase MP (Fisons Fine 
Chemicals, Loughborough, UK) and counted. 
3. RESULTS 
3. I. P~osphory~~tion f tyrosine ~ydroxy~ase by 
Cd’ and phospho~~pid-dependent protein 
kinase 
reported previously, tyrosine hydroxylase 
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Fig. 1. Time course of phosphorylation of purified 
tyrosine hydroxylase by purified protein kinases. 
Tyrosine hydroxylase was incubated with Mg- 
[y-32P]ATP and the following additions: none (v); 
2 mu/ml catalytic subunit of cyclic AMP-dependent 
protein kinase (a); 2 mu/ml calmodulin-dependent 
multiprotein kinase plus CaZt and caImodulin (0); 
0.5 mu/ml rat brain phospholipid-dependent protein 
kinase with (a) or without (0) Ca*’ and 
phosphatidylserine. Phosphorylation in the absence of 
added protein kinase was not affected by addition of 
Ca2+ plus calmodulin or phosphatidylserine. 
Phosphorylation by calmodulin-dependent multiprotein 
kinase was completely dependent on Ca’+ and 
calmodulin (not shown). 
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from rat pheochromocytoma was phosphorylated 
by CAMP-dependent protein kinase and calmodu- 
lin-dependent multiprotein kinase. Tyrosine hy- 
droxylase was also a good substrate for Ca2+ and 
phospholipid-dependent protein kinase purified 
from rat or sheep brain (fig.1). Phosphorylation 
was stimulated 1Cfold by Ca2+ and phosphatidyl- 
serine and the final stoichiometry of phosphoryla- 
tion approached 0.7 mol/mol of the 60-kDa sub- 
unit. With two different preparations of tyrosine 
hydroxylase, initial rates of phosphorylation at 
0.1 mg/ml tyrosine hydroxylase were 95-110% of 
that of histone-Hl at 0.2 mg/ml (not shown). 
Since histone-Hl is one of the best substrates for 
Ca2+ and phospholipid-dependent protein kinase, 
tyrosine hydroxylase would also appear to be an 
excellent substrate for this protein kinase. 
3.2. Comparison of sites phosphorylated on 
tyrosine hydroxylase by phospholipid- 
dependent, calmodulin-dependent and cyclic 
AMP-dependent protein kinases 
Tyrosine hydroxylase was phosphorylated by 
each of the three protein kinases in the presence of 
Mg-[y-32P]ATP. The protein was digested with 
trypsin and 32P-labelled pep tides analysed by 
reversed-phase HPLC. Cyclic AMP-dependent 
and phospholipid-dependent protein kinase both 
phosphorylated a major 32P-labelled peptide (A), 
which comigrated on HPLC (fig.2). In contrast, 
calmodulin-dependent protein kinase phosphory- 
lated two major 32P-labelled peptides, C and A, 
the latter having an identical retention time to the 
peptide labelled by the cyclic AMP- and phospho- 
lipid-dependent protein kinases. Peptide A re- 
presents a secondary site of phosphorylation by the 
calmodulin-dependent protein kinase, since pep- 
tide C predominates when phosphorylation is per- 
formed with lower concentrations of protein 
kinase ([S] and D.G.H., unpublished). 
Tyrosine hydroxylase was phosphorylated by the 
three protein kinases either individually or in com- 
bination, digested with trypsin, and peptide A 
purified by HPLC. Isoelectric focussing on thin- 
layer polyacrylamide showed a single 32P-labelled 
peptide of pZ = 4 in every case (not shown). Since 
isoelectric focussing would resolve mono- and di- 
phosphorylated forms of the same peptide (see e.g. 
[19]), the results obtained using combinations of 
two protein kinases suggested that the three pro- 
tein kinases phosphorylated the same residue in 
peptide A. This was confirmed by sequencer 
analysis of peptide A. A ‘burst’ of radioactivity oc- 
curred after the third cycle of Edman degradation, 
whether tyrosine hydroxylase was phosphorylated 
by cyclic AMP-dependent, calmodulin-dependent 
or phospholipid-dependent protein kinase (fig.3). 
Isoelectric focussing was also carried out on pep- 
tide C labelled by the calmodulin-dependent pro- 
tein kinase, revealing that it was more acidic than 
peptide A, with a plof about 3. Sequencer analysis 
of peptide C also resulted in a ‘burst’ of 32P- 
radioactivity after three cycles of Edman degrada- 
tion, while thin-layer electrophoresis at pH 1.9 
after partial acid hydrolysis revealed that serine 
was the only phosphorylated amino acid (not 
shown). 
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Fig.2. Reversed-phase HPLC analysis of tryptic peptides 
derived from 32P-labelled tyrosine hydroxylase. CAMP 
PK, enzyme labelled to 1.3 mol/subunit using cyclic 
AMP-dependent protein kinase (10 mu/ml). PKC, 
enzyme labelled to 0.7 mol/subunit using sheep brain 
Ca2+ and phospholipid-dependent protein kinase 
(4 mu/ml). Cal PK, enzyme labelled to 1.3 mol/subunit 
using the calmodulin-dependent multiprotein kinase 
(20 mU/ml). The small peak eluting at 42 min in each 
run was also observed when this preparation of tyrosine 
hydroxylase was incubated in the presence of 
[T-~~P]ATP without added protein kinase and appears to 
be due to trace contamination of the enzyme preparation 
with an unidentified protein kinase. 
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4. DISCUSSION 
These results show that tyrosine hydroxylase 
from an adrenal tumour is a good substrate for the 
Ca2+ and phospholipid-dependent protein kinase 
in vitro, with near-stoichiometric phosphorylation 
of the identical residue phosphorylated by cyclic 
AMP-dependent protein kinase. Since phosphory- 
lation of peptide A by cyclic AMP-dependent pro- 
tein kinase increases tyrosine hydroxylase activity 
[8], phosphorylation by phospholipid-dependent 
protein kinase should be accompanied by a similar 
activation. This is supported by the recent work of 
Albert et al. [20], who have independently found 
that tyrosine hydroxylase can be phosphorylated 
and activated by the phospholipid-dependent pro- 
tein kinase. They also reported that the phosphory- 
lation occurs on a serine residue in the same pep- 
tide labelled by cyclic AMP-dependent protein 
kinase. 
We previously reported that the secondary site 
phosphorylated by the calmodulin-dependent pro- 
tein kinase comigrated with peptide A on HPLC. 
However, phosphorylation did not appear to be 
accompanied by activation of tyrosine hydrox- 
ylase, and it was suggested that the calmodulin- 
dependent protein kinase must phosphorylate a 
different residue within peptide A. The present 
work has shown this conclusion to be incorrect. 
The site in peptide A phosphorylated by 
calmodulin-dependent protein kinase is clearly 
identical to that phosphorylated by the cyclic 
AMP-dependent and phospholipid-dependent pro- 
tein kinases. A likely explanation for our failure to 
detect activation of tyrosine hydroxylase by 
calmodulin-dependent protein kinase is suggested 
by the recent work of Albert et al. [ZO]. They 
showed that activation of tyrosine hydroxylase by 
the phospholipid-dependent protein kinase was 
transient. The more active phosphorylated form of 
tyrosine hydroxylase appears to be unstable, so 
that activation is rapidly followed by inhibition of 
the enzyme [21,22]. Perhaps, this inactivation is 
accentuated in the presence of Ca2+ and/or 
calmodulin. Yamauchi et al. [23] have reported 
that the calmodulin-dependent multiprotein kinase 
from rat brain, which is closely related to the 
skeletal muscle enzyme 1241, can activate tyrosine 
hydroxylase from adrenal medulla, provided that 
an additional ‘activator protein’ is present in the 
incubations. It seems possible that the ‘activator 
protein’ is functioning in their system by stabilising 
the phosphorylated form of tyrosine hydroxylase. 
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Fig.3. Release of “P radioactivity during successive 
cycles of Edman degradation of peptide A labelled 
using: cyclic AMP-dependent protein kinase (0); sheep 
brain phospholipid-dependent protein kinase (0); and 
the calmodulin-dependent protein kinase (0). Amounts 
added to the spinning cup were 123000 cpm, 
76266 cpm, and 50385 cpm, respectively. The low 
recovery of radioactivity is due to extensive breakdown 
of phosphoserine during the cleavage step to free 
phosphate, which is only partially extracted from the 
cup by butylchloride. Similar yields (l-5% in the cycle 
containing the phosphoamino acid) are obtained when 
peptides of defined sequences are analysed. 
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Treatment of adrenal medullary cells with 
acetylcholine stimulates phosphorylation of two 
tryptic peptides in tyrosine hydroxylase [6]. 
However, only the peptide with the least anodic 
migration at pH 6.0 or 7.4 was stimulated by 
8-bromo-cyclic AMP. It is tempting to equate pep- 
tide A (isoelectric point = 4) with the less acidic 
peptide phosphorylated in response to both 
acetylcholine and 8-bromo-cyclic AMP, and pep- 
tide C (isoelectric point = 3) with the more acidic 
peptide phosphoryIated only in response to 
acetylcholine. While further work is required to 
confirm that the peptides phosphorylated in intact 
cells are identical with those phosphorylated on the 
purified enzyme, it is clear that activation of the 
calmodulin-dependent protein kinase could ac- 
count for the increased phosphorylation of both 
peptides in response to acetylcholine, whereas ac- 
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tivation of the cyclic AMP-dependent or 
phospholipid-dependent protein kinases could not. 
Since peptides A and C are generated by tryptic 
digestion, the primary structure N-terminal to 
these sites should be lys/arg-x-x-ser(P), which is 
typical of sites phosphorylated by cyclic AMP- 
dependent protein kinase [25] and the calmodulin- 
dependent multiprotein kinase [26]. Furthermore, 
it is known that both sites reside in the same 
37 kDa cyanogen bromide peptide [8]. This infor- 
mation should aid identification of the 
phosphorylation sites in the primary structure, 
when the cDNA sequence [27] has been completed. 
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